|
🐜
|
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
28 auth.
M. Chalabi,
Lorenzo F. Fanchi,
K. Dijkstra,
J. G. van den Berg,
A. Aalbers,
K. Sikorska,
M. Lopez-Yurda,
C. Grootscholten,
G. Beets,
P. Snaebjornsson,
M. Maas,
Marjolijn Mertz,
Vivien Veninga,
G. Bounova,
A. Broeks,
...
R. Beets-Tan,
T. D. de Wijkerslooth,
A. V. van Lent,
H. Marsman,
E. Nuijten,
N. Kok,
M. Kuiper,
W. Verbeek,
M. Kok,
M. V. van Leerdam,
T. Schumacher,
E. Voest,
J. Haanen
|
9 |
2020 |
9
🐜
|
|
🐬
|
Symptom prevalence in patients with incurable cancer: a systematic review.
S. Teunissen,
Wendy Wesker,
C. Kruitwagen,
H. D. de Haes,
E. Voest,
A. de Graeff
|
9 |
2007 |
9
🐬
|
|
🐢
|
Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids
24 auth.
K. Dijkstra,
C. M. Cattaneo,
F. Weeber,
M. Chalabi,
J. L. D. Haar,
Lorenzo F. Fanchi,
M. Slagter,
D. L. Velden,
S. Kaing,
S. Kelderman,
...
N. Rooij,
M. Leerdam,
A. Depla,
E. Smit,
K. Hartemink,
R. Groot,
M. Wolkers,
Norman Sachs,
P. Snaebjornsson,
K. Monkhorst,
J. Haanen,
H. Clevers,
T. Schumacher,
E. Voest
|
9 |
2018 |
9
🐢
|
|
🐜
|
Pan-cancer whole-genome analyses of metastatic solid tumours
21 auth.
P. Priestley,
Jonathan Baber,
M. Lolkema,
N. Steeghs,
Ewart de Bruijn,
C. Shale,
Korneel Duyvesteyn,
S. Haidari,
Arne van Hoeck,
W. Onstenk,
...
P. Roepman,
Mircea Voda,
H. Bloemendal,
V. Tjan-Heijnen,
C. V. van Herpen,
M. Labots,
P. Witteveen,
E. Smit,
S. Sleijfer,
E. Voest,
E. Cuppen
|
9 |
2019 |
9
🐜
|
|
🐬
|
Shared and separate functions of polo-like kinases and aurora kinases in cancer
S. Lens,
E. Voest,
R. Medema
|
9 |
2010 |
9
🐬
|
|
🐢
|
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
23 auth.
S. Ooft,
F. Weeber,
K. Dijkstra,
C. McLean,
S. Kaing,
E. van Werkhoven,
L. Schipper,
L. Hoes,
D. Vis,
J. van de Haar,
...
W. Prevoo,
P. Snaebjornsson,
D. L. van der Velden,
M. Klein,
M. Chalabi,
H. Boot,
M. V. van Leerdam,
H. Bloemendal,
L. Beerepoot,
L. Wessels,
E. Cuppen,
H. Clevers,
E. Voest
|
8 |
2019 |
8
🐢
|
|
🐜
|
Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
19 auth.
W. Scheper,
S. Kelderman,
Lorenzo F. Fanchi,
C. Linnemann,
G. Bendle,
M. A. de Rooij,
C. Hirt,
Riccardo Mezzadra,
M. Slagter,
K. Dijkstra,
...
R. J. Kluin,
P. Snaebjornsson,
K. Milne,
B. Nelson,
H. Zijlmans,
G. Kenter,
E. Voest,
J. Haanen,
T. Schumacher
|
8 |
2018 |
8
🐜
|
|
🐜
|
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.
18 auth.
Y. Shaked,
E. Henke,
J. Roodhart,
P. Mancuso,
M. Langenberg,
M. Colleoni,
L. Daenen,
S. Man,
P. Xu,
U. Emmenegger,
...
T. Tang,
Zhen-ping Zhu,
L. Witte,
R. Strieter,
F. Bertolini,
E. Voest,
R. Benezra,
R. Kerbel
|
8 |
2008 |
8
🐜
|
|
🐜
|
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.
18 auth.
M. Kuroki,
E. Voest,
E. Voest,
E. Voest,
S. Amano,
S. Amano,
L. Beerepoot,
L. Beerepoot,
L. Beerepoot,
S. Takashima,
...
M. Tolentino,
M. Tolentino,
R. Y. Kim,
R. Rohan,
K. Colby,
K. Yeo,
A. Adamis,
A. Adamis
|
8 |
1996 |
8
🐜
|
|
🐜
|
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.
18 auth.
M. Kuroki,
E. Voest,
E. Voest,
E. Voest,
S. Amano,
S. Amano,
L. Beerepoot,
L. Beerepoot,
L. Beerepoot,
S. Takashima,
...
M. Tolentino,
M. Tolentino,
R. Y. Kim,
R. Rohan,
K. Colby,
K. Yeo,
A. Adamis,
A. Adamis
|
8 |
1996 |
8
🐜
|
|
🐜
|
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.
18 auth.
M. Kuroki,
E. Voest,
E. Voest,
E. Voest,
S. Amano,
S. Amano,
L. Beerepoot,
L. Beerepoot,
L. Beerepoot,
S. Takashima,
...
M. Tolentino,
M. Tolentino,
R. Y. Kim,
R. Rohan,
K. Colby,
K. Yeo,
A. Adamis,
A. Adamis
|
8 |
1996 |
8
🐜
|
|
🐢
|
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery.
F. Weeber,
S. Ooft,
K. Dijkstra,
E. Voest
|
8 |
2017 |
8
🐢
|
